These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 25046200)
1. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers. Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200 [TBL] [Abstract][Full Text] [Related]
2. Update of the Swedish two-county program of mammographic screening for breast cancer. Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926 [TBL] [Abstract][Full Text] [Related]
3. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study. Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311 [TBL] [Abstract][Full Text] [Related]
4. Mammographic tumour appearance and triple-negative breast cancer associated with long-term prognosis of breast cancer death: a Swedish Cohort Study. Tsau HS; Yen AM; Fann JC; Wu WY; Yu CP; Chen SL; Chiu SY; Tabár L; Kuo WH; Chen HH; Chang KJ Cancer Epidemiol; 2015 Apr; 39(2):200-8. PubMed ID: 25731718 [TBL] [Abstract][Full Text] [Related]
5. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024 [TBL] [Abstract][Full Text] [Related]
6. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program. Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756 [TBL] [Abstract][Full Text] [Related]
7. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443 [TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma with basal phenotype: mammographic findings. Luck AA; Evans AJ; James JJ; Rakha EA; Paish EC; Green AR; Ellis IO AJR Am J Roentgenol; 2008 Aug; 191(2):346-51. PubMed ID: 18647900 [TBL] [Abstract][Full Text] [Related]
9. Independent prognostic value of screen detection in invasive breast cancer. Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218 [TBL] [Abstract][Full Text] [Related]
10. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement? Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360 [TBL] [Abstract][Full Text] [Related]
11. Risk factors and tumor characteristics of interval cancers by mammographic density. Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer screening by mammography in women aged under 50 years in Japan. Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440 [TBL] [Abstract][Full Text] [Related]
13. Tumor characteristics in screen-detected and symptomatic breast cancers. Pálka I; Kelemen G; Ormándi K; Lázár G; Nyári T; Thurzó L; Kahán Z Pathol Oncol Res; 2008 Jun; 14(2):161-7. PubMed ID: 18347932 [TBL] [Abstract][Full Text] [Related]
14. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331 [TBL] [Abstract][Full Text] [Related]
15. Early breast cancer deaths in women aged 40-74 years diagnosed during the first 5 years of organised mammography service screening in north Sweden. Bordás P; Jonsson H; Nyström L; Cajander S; Lenner P Breast; 2004 Aug; 13(4):276-83. PubMed ID: 15325661 [TBL] [Abstract][Full Text] [Related]
16. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial. Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299 [TBL] [Abstract][Full Text] [Related]
17. Association between mammographic breast density and breast cancer tumor characteristics. Aiello EJ; Buist DS; White E; Porter PL Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):662-8. PubMed ID: 15767347 [TBL] [Abstract][Full Text] [Related]
18. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value? Biesheuvel C; Czene K; Orgeás CC; Hall P Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933 [TBL] [Abstract][Full Text] [Related]
19. The mammographic correlations with Basal-like phenotype of invasive breast cancer. Wang X; Chao L; Chen L; Ma G; Jin G; Hua M; Zhou G Acad Radiol; 2010 Mar; 17(3):333-9. PubMed ID: 19962918 [TBL] [Abstract][Full Text] [Related]
20. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Ernst MF; Voogd AC; Coebergh JW; Roukema JA Cancer; 2004 Apr; 100(7):1337-44. PubMed ID: 15042665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]